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iThe VIRTUE Registry of Type B Thoracic Dissections – Study Design
and Early Results
The VIRTUERegistry Investigators. Eur J Vasc Endovasc Surg 2011;41:8-15.
Introduction: Endovascular procedures for repair of Type B aortic
dissection have become increasingly common and are often considered to be
first line therapy for acute complicated dissections. The long term durability
of these repairs is largely undefined.
Methods: The Virtue Registry is a prospective, non-randomised, multi
centre European Clinical Registry designed to inform on the clinical and
morphological outcomes of 100 patients with Type B aortic dissection
treated with the Medtronic Valiant thoracic stent graft. Patients with acute,
sub-acute and chronic Type B dissections will be prospectively followed for
three years. Clinical outcomes and aortic morphology will be defined.
Results: Fifty patients had an acute dissection, 24 a sub-acute dissec-
tion and 26 a chronic lesion. The 30-day mortality for the acute, sub-acute
and chronic lesions was 8%, 0% and 0%. The in hospital composite outcome
(mortality, stroke or paraplegia) for the three groups was 16%, 0% and 3.8%
respectively. The effect of left subclavian artery (LSCA) revascularisation was
defined with the composite endpoint of patients with a covered, non-
revascularised LSCA being 20% as compared to 5.8% in the covered,
revascularised group.
Conclusion: The early outcomes for the treatment of Type B aortic
dissection are reported in the Virtue Registry. Longer term follow-up is
planned to report on clinical and morphological outcomes up to 36 months
post-procedure.
Prospective Comparative Analysis of Colour-Doppler Ultrasound,
Contrast-enhanced Ultrasound, Computed Tomography and Mag-
netic Resonance in Detecting Endoleak after Endovascular Abdominal
Aortic Aneurysm Repair
Cantisani V., Ricci P., Grazhdani H., Napoli A., Fanelli F., Catalano C., Galati G.,
D’Andrea V., Biancari F., Passariello R. Eur J Vasc Endovasc Surg 2011;41:35-41.
Objectives: To assess the accuracy of colour-Doppler ultrasound
(CDUS), contrast-enhanced ultrasonography (CEUS), computed tomography
angiography (CTA) and magnetic resonance angiography (MRA) in detecting
endoleaks after endovascular abdominal aortic aneurysm repair (EVAR).
Design: Prospective, observational study.
Materials and methods: From December 2007 to April 2009, 108
consecutive patients who underwent EVAR were evaluated with CDUS,
CEUS, CTA and MRA as well as angiography, if further treatment was
necessary. Sensitivity, specificity, accuracy and negative predictive value of
ultrasound examinations were compared with CTA and MRA as the refer-
ence standards, or with angiography when available.
Results: Twenty-four endoleaks (22%, type II: 22 cases, type III: two
cases) were documented. Sensitivity and specificity of CDUS, CEUS, CTA,
and MRA were 58% and 93%, 96% and 100%, 83% and 100% and 96% and
100% respectively. CEUS allowed better classification of endoleaks in 10,
two and one patients compared with CDUS, CTA and MRA, respectively.
Conclusions: The accuracy of CEUS in detecting endoleaks after
EVAR is markedly better than CDUS and is similar to CTA and MRA.
CEUS seems to be a feasible tool in the long-term surveillance after EVAR,
and it may better classify endoleaks missed by other imaging techniques.
Severe Proximal Aneurysm Neck Angulation: Early Results Using the
Endurant Stentgraft System
BastosGonçalvesF.,deVries J.-P.P.M.,vanKeulenJ.W.,DekkerH.,MollF.L.,van
Herwaarden J.A., VerhagenH.J.M. Eur J Vasc Endovasc Surg 2011;41:42-9.
Objective: Angulation of the proximal aneurysm neck has been asso-
ciated with adverse outcome after EVAR.We aim to investigate the influence
of angulation on early results when using the Endurant Stentgraft System.
Methods:A retrospective analysis of a prospectivemulticentre database
identified 45 elective patients treated with the Endurant stentgraft with
severe angulation of the proximal neck, which were compared to a control
group without significant angulation. Endpoints were early technical and
clinical success, deployment accuracy and differences in operative details.Readers can access EJVES articles at http://intl.engulated group had larger aneurysms (mean 309 cc vs. 187 cc), shorter
ecks (mean 27 mm  14 vs. 32.6 mm  13) and 74% (vs. 56%) were ASA
II/IV. Technical success was 100%, with one patient requiring an un-
lanned proximal extension. No differences were found regarding early
ype-I endoleaks (0% vs. 0%), major postoperative complications (6.7% vs.
.2%; p  0.77) or early survival (97.8% vs. 96.9%, p  0.79). Distance from
owest renal artery to prosthesis was 2.4 mm  2.7 vs. 2.3 mm  4.8,
 0.9. Operative details were equivalent for both groups.
Conclusions: Treatment with the Endurant stentgraft is technically
easible and safe, with satisfactory results in angulated and non-angulated
natomies alike. No sealing length was lost in extremely angulated cases,
onfirming the device’s high conformability. Mid- and long-term data are
waited to verify durability, but early results are promising and challenge
urrent opinion concerning neck angulation.
Systematic Literature Review of the Efficacy and Safety of the Prostar
L Device for the Closure of Large Femoral Arterial Access Sites in
atients Undergoing Percutaneous Endovascular Aortic Procedures
aulon S., Hassen Khodja R., Proudfoot C.W., Samuels E. Eur J Vasc
ndovasc Surg 2011;41:50-63.
Objectives: To identify and analyse existing evidence from published studies
valuating the efficacy and safety of a percutaneous vessel closure device for the
losure of large arterial femoral arterial access sites (10 French).
Design:This study was a systematic literature review andmeta-analysis.
Materials and methods: Electronic databases were searched for stud-
es published on the evaluation of the Prostar XL vessel closure device. There
as no restriction by study design or patient population. Appraisal of studies
or inclusion and data extraction were performed independently by two
eviewers. Meta-analysis was performed where feasible.
Results: Twenty-one studies were included, which reported data specifically
or closureof large (10Fr) femoral arterial access sites using theProstarXLdevice.
heProstarXLdevice, used for closureof these large femoral artery access sites, had
high rate of procedural success equal to that reported for closure by femoral artery
urgical cut-down. There was evidence for reduced procedural time, time to dis-
hargeand time toambulation.Complication rateswere lower,butnot significantly
o, with Prostar XL vs. surgical cut-down.
Conclusions: The Prostar XL is an effective and safe device for use in
ercutaneous closure of large (10 Fr) femoral artery access sites, comparable
o open surgical femoral artery cut-down. Furthermore, it may reduce proce-
ure times and hospitalisations, thereby leading to potential cost savings.
apid Access Carotid Endarterectomy can be Performed in the Hyper-
cute Period without a Significant Increase in Procedural Risks
alem M.K., Sayers R.D., Bown M.J., Eveson D.J., Robinson T.G., Naylor
.R. Eur J Vasc Endovasc Surg 2011;41:72-8.
Objectives: The highest risk of recurrent stroke after suffering a
ransient ischaemic attack (TIA) or minor stroke is during the first 7–14
ays. Contemporary guidelines recommend that carotid endarterectomy
CEA) should be performed within this time period, but there are concerns
egarding (1) how this can be achieved logistically and (2) whether this
olicy is associated with a significant increase in procedural risks.
Design: This is a prospective, consecutive study of delays to surgery
nd 30-day outcomes in recently symptomatic patients who underwent CEA
etween 1 October 2008 and 15 June 2010 after the creation of a rapid
ccess TIA service.
Results: A total of 109 symptomatic patients underwent CEA, 78%
ithin 14 days of the index event and 90% within 14 days of referral. The
edian delay to surgery was 9 days from the index event and 4 days from
eferral. There were no perioperative deaths. Two strokes occurred (one
ntra-operative and one post-operative) to give a 30-day death/stroke rate of
.83%. Patients undergoing CEA within 14 days of the index event incurred
death/stroke rate of 2.4% (2/84), increasing to 4.3% in patients undergo-
ng surgery within 7 days (2/47).
Conclusion: Service reconfigurations can lead to significant reductions
n delays to treatment in patients with symptomatic carotid disease. CEA canResults: Mean age was 74 with 86.4%males. Mean infrarenal angle ()
was 80.8°16 and mean suprarenal angle () was 51.4°21. Patients in the
be performed in the hyperacute period without significantly increasing the
operative risk.lsevierhealth.com/journals/ejvs/default.cfm
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